BamSEC and AlphaSense Join Forces
Learn More

Kolltan Pharmaceuticals Inc

Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.17
from S-1/A 17 pages Indemnification Agreement
12/34/56
EX-10.16
from S-1 11 pages Material contract
12/34/56
EX-10.15
from S-1 40 pages Confidential Materials Omitted and Filed Separately With the Securities and Exchange Commission. Double Asterisks Denote Omissions. License Agreement Between Lonza Sales AG and Kolltan Pharmaceuticals, Inc. Index
12/34/56
EX-10.14
from S-1 138 pages Confidential Materials Omitted and Filed Separately With the Securities and Exchange Commission. Double Askterisks Denote Omissions. Development and Manufacturing Services Agreement Between Lonza Sales AG and Kolltan Pharmaceuticals, Inc
12/34/56
EX-10.13
from S-1 12 pages Amended and Restated Consulting Agreement
12/34/56
EX-10.12
from S-1 46 pages Confidential Materials Omitted and Filed Separately With the Securities and Exchange Commission. Double Asterisks Denote Omissions. Third Amended and Restated License Agreement
12/34/56
EX-10.11
from S-1 26 pages Confidential Materials Omitted and Filed Separately With the Securities and Exchange Commission. Double Asterisks Denote Omissions. Amended and Restated Research Agreement
12/34/56
EX-10.10
from S-1 39 pages Background Article 1 Definitions
12/34/56
EX-10.9
from S-1 113 pages Confidential Materials Omitted and Filed Separately With the Securities and Exchange Commission. Double Asterisks Denote Omissions. License and Option Agreement by and Between Medimmune, LLC and Bulldog Pharmaceuticals, Inc
12/34/56
EX-10.8
from S-1 104 pages Lease Agreement Between We George Street, L.L.C. ("Landlord") and Kolltan Pharmaceuticals Inc
12/34/56
EX-10.3
from S-1 10 pages Kolltan Pharmaceuticals, Inc. Nonqualified Stock Option Agreement Granted Under 2008 Equity Incentive Plan
12/34/56
EX-10.2
from S-1 10 pages Kolltan Pharmaceuticals, Inc. Incentive Stock Option Agreement Granted Under 2008 Equity Incentive Plan
12/34/56
EX-10.1
from S-1 23 pages Kolltan Pharmaceuticals, Inc. 2008 Equity Incentive Plan (Effective July 23, 2008) (Amended and Restated as of February 27, 2009) Kolltan Pharmaceuticals, Inc. Equity Incentive Plan Section 1 Background and Purpose
12/34/56
EX-10.21
from DRS 11 pages Material contract
12/34/56
EX-10.20
from DRS 40 pages Confidential Materials Omitted and Filed Separately With the Securities and Exchange Commission. Double Asterisks Denote Omissions. License Agreement Between Lonza Sales AG and Kolltan Pharmaceuticals, Inc. Index
12/34/56
EX-10.19
from DRS 138 pages Confidential Materials Omitted and Filed Separately With the Securities and Exchange Commission. Double Askterisks Denote Omissions. Development and Manufacturing Services Agreement Between Lonza Sales AG and Kolltan Pharmaceuticals, Inc
12/34/56
EX-10.18
from DRS 12 pages Amended and Restated Consulting Agreement
12/34/56
EX-10.17
from DRS 46 pages Confidential Materials Omitted and Filed Separately With the Securities and Exchange Commission. Double Asterisks Denote Omissions. Third Amended and Restated License Agreement
12/34/56
EX-10.16
from DRS 26 pages Confidential Materials Omitted and Filed Separately With the Securities and Exchange Commission. Double Asterisks Denote Omissions. Amended and Restated Research Agreement
12/34/56
EX-10.15
from DRS 39 pages Background Article 1 Definitions
12/34/56